Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
Aurinia Pharmaceuticals Inc. (AUPH)
|
|
Operating Efficiency |
|
|
|
|
Annual |
|
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 |
| Source | Source | Source | Source | Source | Source | Source |
Turnover Ratios |
Inventory turnover | 0.3 | 0.1 | 0.0 | | | | |
Asset turnover | 0.3 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | |
|
Returns on Capital |
ROIC (excluding intangibles) | -37.6% | -82.9% | -117.7% | -455.9% | -217.4% | -261.2% | |
ROIC (including intangibles) | -33.8% | -64.2% | -60.3% | -408.7% | -208.5% | -191.8% | -239.1% |
ROE | -28.0% | -37.9% | -25.6% | -30.5% | -49.1% | -28.2% | -75.8% |
ROA | -24.1% | -33.4% | -22.5% | -28.1% | -37.9% | -24.6% | -47.8% |
|
Cash Conversion Cycle |
Days sales outstanding | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Days payables outstanding | 198.9 | 1,297.7 | | | | | |
Days inventory outstanding | 1,595.1 | 6,465.6 | | | | | |
Cash conversion cycle | 1,396.1 | 5,167.9 | | | | 0.0 | 0.0 |
|